Amgen Seeks To Toss Investor Claims Of $10B Hidden Tax Bill
Amgen Inc. asked a New York federal judge to scrap a shareholder suit claiming the biotech company hid a $10 billion tax bill from investors, arguing it wasn't required to disclose...To view the full article, register now.
Already a subscriber? Click here to view full article